Table of Contents
Overview
Although mutations in MTOR have been reported in DLBCL and some BL, their role in lymphomagenesis has not been thoroughly studied.
Experimental Evidence
Driver mutations affecting this gene in DLBCL have been experimentally demonstrated to cause a gain of function (GOF).1
Relevance tier by entity
| Entity | Tier | Description |
|---|---|---|
| 3 | Mutations are unlikely to be relevant to BL | |
| 1 | High-confidence DLBCL gene |
Warnings
The variants reported in this gene in BL failed QC
Mutation incidence in large patient cohorts (GAMBL reanalysis)
DLBCL
| Entity | Collection | N | mutated | Incidence | 95% CI |
|---|---|---|---|---|---|
| DLBCL | GAMBL without Reddy | 1,089 | 36 | 0.0331 | [0.0224,0.0437] |
| DLBCL | GAMBL with Reddy | 2,088 | 60 | 0.0287 | [0.0216,0.0359] |
| DLBCL | BC | 231 | 4 | 0.0173 | [5e-04,0.0341] |
| DLBCL | Dana-Farber | 303 | 6 | 0.0198 | [0.0041,0.0355] |
| DLBCL | NCI | 470 | 19 | 0.0404 | [0.0226,0.0582] |
| DLBCL | Reddy | 999 | 24 | 0.0240 | [0.0145,0.0335] |
| DLBCL | DLBCL_ICGC | 85 | 7 | 0.0824 | [0.0239,0.1408] |
BL
| pathology | Collection | N | mutated | Incidence | CI |
|---|---|---|---|---|---|
| BL | GAMBL without Panea | 309 | 8 | 0.0208 | [0.0049,0.0366] |
| BL | GAMBL without ICGC/Zhou | 320 | 19 | 0.0424 | [0.0205,0.0642] |
| BL | GAMBL with Panea | 410 | 20 | 0.0266 | [0.0112,0.042] |
| BL | BLGSP | 219 | 7 | 0.0320 | [0.0087,0.0553] |
| BL | Zhou/ICGC | 90 | 1 | 0.0111 | [0,0.0328] |
| BL | Panea | 101 | 12 | 0.1188 | [0.0557,0.1819] |
Mutation pattern and selective pressure estimates
Failed to render page: conflicting chdir during another chdir block
MTOR Hotspots
| Chromosome | Coordinate (hg19) | ref>alt | HGVSp |
|---|---|---|---|
| chr1 | 11169376 | A>T | I2500N |
Failed to render page: conflicting chdir during another chdir block
Expression
Representative Mutations
BL
Rating ★ ☆ ☆
☆ ☆
Rating ★ ☆ ☆
☆ ☆
Failed to render page: conflicting chdir during another chdir block
References
1.
Grabiner BC, Nardi V, Birsoy K, Possemato R,
Shen K, Sinha S, Jordan A, Beck AH, Sabatini DM. A diverse array of
cancer-associated MTOR mutations are hyperactivating and
can predict rapamycin sensitivity. Cancer Discov. 2014 May;4(5):554–563.
PMCID: PMC4012430
2.
Panea R, Love C, Shingleton JR, Reddy A, Bailey
J, Moormann A, Otieno J, Ong’echa J, Oduor C, Schroêder K, Masalu N,
Chao N, Agajanian M, Major M, Fedoriw Y, Richards K, Rymkiewicz G, Miles
R, Alobeid B, Bhagat G, Flowers C, Ondrejka S, Hsi E, Choi W, Au-Yeung
R, Hartmann W, Lenz G, Meyerson H, Lin YY, Zhuang Y, Luftig M, Waldrop
A, Dave T, Thakkar D, Sahay H, Li G, Palus B, Seshadri V, Kim S,
Gascoyne R, Levy S, Mukhopadhyay M, Dunson D, Dave S. The whole genome
landscape of Burkitt lymphoma subtypes. Blood. 2019;
3.
Reddy A, Zhang J, Davis NS, Moffitt AB, Love
CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg
ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W,
Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y,
Bernal-Mizrachi L, Koff JL, Staton AD, Flowers CR, Paltiel O,
Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader MB,
Ondrejka SL, Collie A, Hsi ED, Tse E, Au-Yeung RKH, Kwong YL, Srivastava
G, Choi WWL, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn
A, Gordon LI, Jaffe ES, Levy S, Rempel R, Tzeng T, Happ LE, Dave T,
Rajagopalan D, Datta J, Dunson DB, Dave SS. Genetic and Functional
Drivers of Diffuse Large B Cell Lymphoma. Cell. 2017
Oct;171(2):481–494.e15. PMCID: PMC5659841
4.
Zhang J, Grubor V, Love CL, Banerjee A,
Richards KL, Mieczkowski PA, Dunphy C, Choi W, Au WY, Srivastava G,
Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers C,
Naresh K, Evens A, Gordon LI, Czader M, Gill JI, Hsi ED, Liu Q, Fan A,
Walsh K, Jima D, Smith LL, Johnson AJ, Byrd JC, Luftig MA, Ni T, Zhu J,
Chadburn A, Levy S, Dunson D, Dave SS. Genetic heterogeneity of diffuse
large B-cell lymphoma. Proceedings of the
National Academy of Sciences of the United States of America.
2013;110:1398–1403. PMCID: PMC3557051

